BB Biotech 2nd Line Ord Shs (BBZA) Cena delnic in novice – Google Finance

Domača stranBBZA • FRA

BB Biotech 2nd Line Ord Shs

40,15 €

15. jan., 22:15:00 GMT +1 · EUR · FRA · Izjava

HLB Inc

74.700,00 ₩

0283005,92 %

Hualan Biological Engineering Inc

15,92 ¥

0020070,063 %

Sichuan Kelun-Biotech Biophrmctcl Co Ltd

161,80 $

69904,77 %

WuXi Biologics (Cayman) Inc

17,42 $

22691,02 %

Innovent Biologics Inc

33,45 $

18013,46 %

Ocumension Therapeutics

3,72 $

14772,36 %

AIXTRON SE

9,37 CHF

AIXA0,00 %

Befesa SA

20,08 €

BFSA1,08 %

Metro AG

4,86 €

B4B32,97 %

Siltronic AG

43,94 €

WAF0,41 %

DelnicaVrednostni papir, ki kotira v DESedež podjetja: CH

Prejšnji trg. dan.

40,55 €

Dnevni razpon

39,90 € - 40,60 €

Letni razpon

36,90 € - 52,60 €

Tržna kapitalizacija

2,11 mrd. CHF

Povprečni obseg

3,37 tis.

Razm. P/E

-

Dividendna donosnost

-

Primarna borza

SWX

Borzne novice

pred 44 minutami

NASDAQ snaps five-day losing streak with its best day since November 6

pred 18 minutami

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.65%

Investor's Business Daily

pred 13 minutami

Dow Jones Futures: Market Retakes Key Levels In Big Rally; Tesla, Meta Lead New Buys

Goldman Sachs, American Express share gains lead Dow's nearly 750-point rally

Financial Times

Investors pour billions into S&P equal weight fund as tech fears rise

The Business Times

US: Wall St opens higher after inflation data, strong bank earnings

Vizitka

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Datum ustanovitve

9. nov. 1993

Sedež organizacije

Küsnacht, Zürich
Švica

Spletno mesto

Iskanje

Počisti iskanje

Zapiranje iskanja

Googlove aplikacije

Glavni meni